IQ Pouch: A New 'Smart Energy' Pouch Aims to Disrupt Nicotine and Caffeine Habits

DENVER, March 6, 2026 – A new player has entered the burgeoning market for cognitive enhancement, aiming to carve out a unique space between the worlds of energy supplements and nicotine alternatives. IQ Pouch Company, Inc. officially launched its flagship product today: a line of nicotine-free, sugar-free nootropic pouches designed to deliver clean focus and energy without the jitters or crashes associated with traditional stimulants.

The product, dubbed "smart energy," leverages a novel core ingredient, enfinity® paraxanthine, and is the latest venture from serial entrepreneur Brad Pyatt. The launch represents a calculated bet on a new category, targeting high-performers seeking sustained mental stamina in a discreet, convenient format.

The Science of Skipping the Crash

At the heart of IQ Pouch's formula is paraxanthine, a compound that may be unfamiliar to most consumers but is intrinsically linked to their morning coffee. When a person consumes caffeine, the liver metabolizes it into three primary compounds: theobromine, theophylline, and paraxanthine. Paraxanthine is the most abundant of these metabolites and is largely responsible for the feelings of increased alertness, focus, and cognitive function that caffeine drinkers seek.

IQ Pouch's strategy is to bypass the metabolic conversion process entirely. "Most people don't realize that when you drink caffeine, your body has to break it down before you get the real performance compound," said founder Brad Pyatt in the company's launch announcement. "That compound is paraxanthine. By delivering it directly, we're able to provide smoother energy, clearer focus, and none of the jittery crash people experience with traditional energy drinks."

Scientific research supports the premise. Studies on enfinity®, the branded version of paraxanthine used in the pouches, suggest it can enhance cognition, memory, and attention with a lower incidence of the side effects commonly linked to caffeine, such as anxiety and sleep disruption. With a shorter half-life than caffeine, paraxanthine is cleared from the body more quickly, making it a more appealing option for afternoon use. The ingredient has received self-affirmed Generally Recognized As Safe (GRAS) status from the U.S. Food and Drug Administration (FDA).

Beyond its star ingredient, IQ Pouch includes a blend of other well-known nootropics. L-Theanine, an amino acid found in green tea, is included to promote a state of calm focus. Cognizin® Citicoline is added for its role in cognitive performance, while the adaptogen Rhodiola rosea is intended to support mental stamina. Vitamins B6 and B12 round out the formula to aid in energy metabolism. The product, which was in development for over three years, is available in Mint Mode, Citrus, and Spiced flavors.

A Founder's High-Stakes Comeback

The story of IQ Pouch is deeply intertwined with the ambitious and complex history of its founder, Brad Pyatt. The company's press release highlights a personal motivation for the product's creation. "I created IQ Pouch out of necessity," Pyatt stated. "After battling a decade-long nicotine habit, I needed something that could replace the ritual without the addiction."

Pyatt is no stranger to the competitive consumer packaged goods (CPG) landscape. He founded the sports nutrition brand MusclePharm in 2006, steering it through a period of explosive growth that made it a dominant force in the industry, with products on the shelves of major retailers worldwide. However, the brand's rapid ascent was followed by significant challenges. In 2015, MusclePharm faced charges from the U.S. Securities and Exchange Commission (SEC) related to accounting and disclosure violations, leading to fines and leadership changes. After years of financial struggle, the company filed for Chapter 11 bankruptcy in late 2022.

While the IQ Pouch press release also credits Pyatt with creating the functional nutrition brand TRUBAR, public records and company history attribute the founding of that successful plant-based protein bar company to Erica Groussman in 2019. This new venture, therefore, represents a critical new chapter for Pyatt, a move to build a brand from the ground up in a new and innovative category.

Tapping into Converging Market Trends

IQ Pouch is launching at the intersection of several powerful consumer trends. The global nootropics market is experiencing a massive boom, valued at over $2.3 billion in 2024 and projected to grow at a compound annual rate of nearly 8% over the next decade. This growth is fueled by a diverse demographic—from students and gamers to entrepreneurs and aging adults—all seeking a mental edge, improved productivity, and long-term brain health.

Simultaneously, the market for nicotine cessation and alternatives is a multi-billion-dollar industry. A growing awareness of the health risks associated with tobacco and nicotine has created a massive consumer base actively searching for non-addictive options that can replace the oral fixation and ritual of using pouches or chewing tobacco.

IQ Pouch is one of the first products to directly fuse these two worlds. It adopts the discreet, convenient oral pouch—a delivery system popularized by the nicotine industry—but fills it with brain-boosting nootropics instead. This positions the product as a unique tool for both focus enhancement and as a potential off-ramp for those looking to quit nicotine without giving up the hand-to-mouth habit.

"Athletes train their bodies every day, but cognitive performance is just as important," Pyatt noted. "IQ Pouch was built for people who demand more from their energy — whether they're competing, building companies, or simply performing at their highest level." The company has signaled its intention to forge partnerships across sports and creator communities, hinting at a broader ambition to cultivate a movement around the concept of smarter energy. As the product hits the digital shelves, the market will ultimately decide if this new formula for focus can live up to its ambitious promise.